These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16493198

  • 41. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
    Jacobs SS, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Erdmann G, Franklin J, Neglia JP, Steinberg SM, Balis FM, Adamson PC, Children's Oncology Group, National Cancer Institute.
    Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
    [Abstract] [Full Text] [Related]

  • 42. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
    Kane S, Cohen SM, Hart J.
    Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
    [Abstract] [Full Text] [Related]

  • 43. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [Abstract] [Full Text] [Related]

  • 44. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
    De Bruyne R, Portmann B, Samyn M, Bansal S, Knisely A, Mieli-Vergani G, Dhawan A.
    J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.
    Bayoumy AB, Jagt JZ, van Wering HM, de Ridder L, Hummel T, Wolters VM, Stapelbroek J, Benninga MA, Mulder CJJ, de Boer NKH, de Meij TGJ, Kids with Crohn’s, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands.
    J Pediatr Gastroenterol Nutr; 2022 Dec 01; 75(6):e111-e115. PubMed ID: 36136124
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 49. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK, van Bodegraven AA, Jharap B, de Graaf P, Mulder CJ.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec 01; 4(12):686-94. PubMed ID: 18043678
    [Abstract] [Full Text] [Related]

  • 50. Thioguanine in inflammatory bowel disease: Long-term efficacy and safety.
    Ward MG, Patel KV, Kariyawasam VC, Goel R, Warner B, Elliott TR, Blaker PA, Irving PM, Marinaki AM, Sanderson JD.
    United European Gastroenterol J; 2017 Jun 01; 5(4):563-570. PubMed ID: 28588888
    [Abstract] [Full Text] [Related]

  • 51. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X.
    Aliment Pharmacol Ther; 2012 Jan 01; 35(1):15-36. PubMed ID: 22050052
    [Abstract] [Full Text] [Related]

  • 52. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease.
    Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, van Deventer SJ, Hommes DW, Hooymans PM.
    Ther Drug Monit; 2006 Feb 01; 28(1):45-50. PubMed ID: 16418693
    [Abstract] [Full Text] [Related]

  • 53. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA, Rawsthorne P, Bernstein CN.
    Am J Gastroenterol; 2004 Sep 01; 99(9):1744-8. PubMed ID: 15330913
    [Abstract] [Full Text] [Related]

  • 54. Tioguanine in the treatment of refractory coeliac disease--a single centre experience.
    Tack GJ, van Asseldonk DP, van Wanrooij RL, van Bodegraven AA, Mulder CJ.
    Aliment Pharmacol Ther; 2012 Aug 01; 36(3):274-81. PubMed ID: 22646133
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
    van Egmond R, Chin P, Zhang M, Sies CW, Barclay ML.
    Aliment Pharmacol Ther; 2012 May 01; 35(10):1181-9. PubMed ID: 22486532
    [Abstract] [Full Text] [Related]

  • 57. [Therapeutic drug monitoring of 6-thioguanine nucleotides in inflammatory bowel disease: interest and limits].
    Jourdil N, Fonrose X, Boulieu R, Stanke-Labesque F, Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 May 01; 65(3):177-86. PubMed ID: 20699068
    [Abstract] [Full Text] [Related]

  • 58. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M, Herrlinger K, Schaeffeler E, Stange EF.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):378-85. PubMed ID: 12594624
    [No Abstract] [Full Text] [Related]

  • 59. A histopathologic pattern of centrilobular hepatocyte injury suggests 6-mercaptopurine-induced hepatotoxicity in patients with inflammatory bowel disease.
    Masia R, Pratt DS, Misdraji J.
    Arch Pathol Lab Med; 2012 Jun 21; 136(6):618-22. PubMed ID: 22646267
    [Abstract] [Full Text] [Related]

  • 60. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M, Hill FG, Wilson DC, Gillett PM, Thomas A, Brown R, Darbyshire PJ, McKiernan PJ.
    J Pediatr Gastroenterol Nutr; 2006 May 21; 42(5):535-8. PubMed ID: 16707977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.